fda semaglutide approval A stronger 7.2 mg dose of Wegovy wins after a 54-day review, promising greater weight loss for eligible patients. || FULL STORY IN COMMENTS Wegovy FDA Approval: CV Risk

In one 12-week study, adding allulose to the standard diet of rats with Type 2 diabetes prevented fatty liver accumulation

This means that the volume of each dose is accurate and consistent from the first to the last treatment from the pack

Not for weight loss

Caspase-6 knockout in 5xFAD mice on the other hand has reduced A pathology and improved performance in anxiety assessment compared to 5xFAD alone (Gao et al., 2018)

What Users Report About Cardiovascular Effects Community reports from Reddit forums, bodybuilding communities, and biohacking platforms provide practical insights that scientific literature cannot capture